Literature DB >> 9844045

Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.

E Sarugeri1, N Dozio, C Belloni, F Meschi, M R Pastore, E Bonifacio.   

Abstract

Type 1 diabetes is associated with autoimmunity to insulin. Genetic susceptibility to type 1 diabetes is polygenic and includes the INS VNTR-IDDM2 locus which may regulate the expression of insulin in pancreas and thymus. In order to determine whether insulin autoimmunity could be attributed to a genetic susceptibility conferred by the INS VNTR-IDDM2 locus, peripheral blood T cell proliferation to human insulin and insulin autoantibodies (IAA) was measured in patients with new onset type 1 diabetes and control subjects. IAA were detected in 21 of 53 patients and in none of 25 control subjects, while T cell responses were low (stimulation index range 0.4-7.2) and similar in both groups. Both antibody and T cell responses were higher in younger subjects and IAA were more prevalent in patients with the HLA-DR4 allele. No relationship was observed between humoral and cellular responses to insulin. No association was found between the INS VNTR-IDDM2-susceptible allele and insulin autoimmunity. Increased T cell responses and IAA were found in patients with either the diabetes-susceptible or the diabetes-protective INS VNTR-IDDM2 locus genotypes, and increased T cell responses were also found in control subjects with either susceptible or protective INS VNTR-IDDM2 locus genotypes. This study confirms that primary T cell proliferative responses to insulin are low and detectable also in control subjects. The detection of T cell proliferation and autoantibodies to insulin in subjects with and without the protective INS VNTR-IDDM2 locus genotypes does not support the hypothesis of an allele-specific capacity for tolerance induction which could determine a susceptibility to develop autoimmunity against the insulin protein and subsequently diabetes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844045      PMCID: PMC1905134          DOI: 10.1046/j.1365-2249.1998.00744.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  Autoreactive T cells in multiple sclerosis.

Authors:  J Zhang; H L Weiner; D A Hafler
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311

2.  Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.

Authors:  L C Harrison; S X Chu; H J DeAizpurua; M Graham; M C Honeyman; P G Colman
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Rapid HLA-DRB1 genotyping by nested PCR amplification.

Authors:  G Bein; R Gläser; H Kirchner
Journal:  Tissue Antigens       Date:  1992-02

4.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; L Campbell; B L Darrow; D L Kaufman; N K Maclaren
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.

Authors:  L C Harrison; M C Honeyman; H J DeAizpurua; R S Schmidli; P G Colman; B D Tait; D S Cram
Journal:  Lancet       Date:  1993-05-29       Impact factor: 79.321

6.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

7.  Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; K J Kao; L Campbell; P J Dush; S C Shah; O Simell; N K Maclaren
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

8.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus.

Authors:  S T Bennett; A M Lucassen; S C Gough; E E Powell; D E Undlien; L E Pritchard; M E Merriman; Y Kawaguchi; M J Dronsfield; F Pociot
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

9.  Suppressive effect of antibody on processing of T cell epitopes.

Authors:  C Watts; A Lanzavecchia
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

10.  Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants.

Authors:  P D Simitsek; D G Campbell; A Lanzavecchia; N Fairweather; C Watts
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

2.  Induction and activation of antiviral enzyme 2',5'-oligoadenylate synthetase by in vitro transcribed insulin mRNA and other cellular RNAs.

Authors:  Meixia Dan; Dongjun Zheng; L Leigh Field; Vagn Bonnevie-Nielsen
Journal:  Mol Biol Rep       Date:  2012-05-01       Impact factor: 2.316

3.  The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.

Authors:  Robert Hermann; A P Laine; R Veijola; T Vahlberg; S Simell; J Lähde; O Simell; M Knip; J Ilonen
Journal:  Diabetologia       Date:  2005-07-16       Impact factor: 10.122

4.  A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin.

Authors:  D G Alleva; P D Crowe; L Jin; W W Kwok; N Ling; M Gottschalk; P J Conlon; P A Gottlieb; A L Putnam; A Gaur
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 5.  Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity.

Authors:  Sebastien Bouret; Barry E Levin; Susan E Ozanne
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 6.  Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.

Authors:  Shubhabrata Majumdar; Yong Lin; Matthew L Bettini
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

7.  Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II.

Authors:  Elizabeth Ramos-Lopez; Britta Lange; Heinrich Kahles; Holger S Willenberg; Gesine Meyer; Marissa Penna-Martinez; Nicole Reisch; Stefanie Hahner; Jürgen Seissler; Klaus Badenhoop
Journal:  BMC Med Genet       Date:  2008-07-11       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.